Shinobu Takeda
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 3
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 5
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Cancer Diagnosis and Treatment 2
-
- Antimicrobial Resistance in Staphylococcus 5
- Antifungal resistance and susceptibility 3
-
- Oral and Maxillofacial Pathology 3
-
- Oral Health Pathology and Treatment 2
Shinobu Takeda
25 papers receiving 744 citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Otorhinolaryngology 194
- Molecular Medicine 195
- Applied Microbiology and Biotechnology 73
- Pharmacology 168
- Oncology 199
Countries citing papers authored by Shinobu Takeda
This map shows the geographic impact of Shinobu Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinobu Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinobu Takeda more than expected).
Fields of papers citing papers by Shinobu Takeda
This network shows the impact of papers produced by Shinobu Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinobu Takeda. The network helps show where Shinobu Takeda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shinobu Takeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironmentbreakdown → | 2022 | 85 |
| 2 | 2022 | 9 | |
| 3 | 2014 | 22 | |
| 4 | 2008 | 6 | |
| 5 | 2008 | 0 | |
| 6 | 2007 | 37 | |
| 7 | 2007 | 52 | |
| 8 | 2006 | 109 | |
| 9 | 2005 | 59 | |
| 10 | 2002 | 195 | |
| 11 | 2002 | 28 | |
| 12 | 2001 | 2 | |
| 13 | 2000 | 3 | |
| 14 | 1999 | 11 | |
| 15 | 1999 | 28 | |
| 16 | The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma. | 1999 | 11 |
| 17 | 1998 | 26 | |
| 18 | [Methicillin-resistant Staphylococcus aureus (MRSA) isolated in hospitals in Fukuoka City area]. | 1992 | 6 |
| 19 | Effects of chelating agents on preimplantation development of mouse embryos fertilized in vitro. | 1989 | 11 |
| 20 | [Clinical investigation of disease in relation to maxillary sinus in our Department. Especially postoperative buccal cyst and maxillary sinusitis]. | 1987 | 1 |
About Shinobu Takeda
Shinobu Takeda is a scholar working on Otorhinolaryngology, Molecular Medicine and Oral Surgery, having authored 26 papers that have together received 771 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antifungal resistance and susceptibility (3 papers), Oral and Maxillofacial Pathology (3 papers), Head and Neck Cancer Studies (3 papers), Oral Health Pathology and Treatment (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (194 citations), Molecular Medicine (195 citations) and Applied Microbiology and Biotechnology (73 citations). Shinobu Takeda has collaborated with scholars based in Japan and Thailand. Frequent co-authors include Kazuo Hatano, Hideo Kurokawa, Yoshihiro Yamashita, Hiroshi Fukuyama, Tetsu Takahashi, Min Zhang, Toru Nakai, Yoshimi Wakai, Fumiaki Ikeda and Kuniaki Toyoshima. Their work appears in journals such as The Journal of Comparative Neurology, FEBS Letters and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.